Common Stock, Shares, Outstanding of Kezar Life Sciences, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kezar Life Sciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Kezar Life Sciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 7,323,106, a 0.37% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Kezar Life Sciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 7,323,106 +26,884 +0.37% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 7,315,931 -65,571,607 -90% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 7,305,800 -65,495,559 -90% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 7,303,629 +25,721 +0.35% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 7,296,222 -65,396,741 -90% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 72,887,538 +354,724 +0.49% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 72,801,359 +1,985,359 +2.8% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 7,277,908 -61,215,521 -89% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 72,692,963 +4,320,848 +6.3% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 72,532,814 +4,191,172 +6.1% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 70,816,000 +11,251,341 +19% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 68,493,429 +12,233,682 +22% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 68,372,115 +19,775,234 +41% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 68,341,642 +20,195,334 +42% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 59,564,659 +11,484,791 +24% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 56,259,747 +9,900,004 +21% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 48,596,881 +2,329,356 +5% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 48,146,308 +2,319,510 +5.1% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 48,079,868 +9,903,406 +26% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 46,359,743 +27,151,666 +141% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 46,267,525 +27,125,880 +142% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 45,826,798 +26,694,153 +140% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 38,176,462 +19,058,041 +100% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 19,208,077 +93,656 +0.49% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 19,141,645 +33,424 +0.18% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 19,132,645 +24,424 +0.13% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 19,118,421 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 19,114,421 +18,165,843 +1915% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 19,108,221 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 19,108,221 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q4 2017 948,578 31 Dec 2017 10-K 26 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.